# Study to Evaluate Efficacy and Tolerability of Two Topical Regimens in Subjects With Moderate to Severe Facial Photodamage Who Have Received Cosmetic Injections

> **NCT03559972** · NA · COMPLETED · sponsor: **Allergan** · enrollment: 40 (actual)

## Conditions studied

- Facial Photodamage

## Interventions

- **OTHER:** on-label facial injection

## Key facts

- **NCT ID:** NCT03559972
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-04
- **Primary completion:** 2018-12-03
- **Final completion:** 2018-12-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03559972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03559972, "Study to Evaluate Efficacy and Tolerability of Two Topical Regimens in Subjects With Moderate to Severe Facial Photodamage Who Have Received Cosmetic Injections". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03559972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*